Bank of America
TEVA icon

Bank of America’s Teva Pharmaceuticals TEVA Stock Holding History

Bank of America’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143M Buy
4,227,607
+268,793
+7% +$8.95M 0.01% 956
2026
Q1 		$119M Sell
3,958,814
-2,453,994
-38% -$78.9M 0.01% 996
2025
Q4 		$200M Sell
6,412,808
-1,149,635
-15% -$28.3M 0.01% 738
2025
Q3 		$153M Sell
7,562,443
-1,442,520
-16% -$25.3M 0.01% 946
2025
Q2 		$151M Buy
9,004,963
+1,473,740
+20% +$23.8M 0.01% 929
2025
Q1 		$116M Buy
7,531,223
+3,517,787
+88% +$62.8M 0.01% 1002
2024
Q4 		$88.5M Sell
4,013,436
-1,935,982
-33% -$35.2M 0.01% 1111
2024
Q3 		$107M Buy
5,949,418
+638,262
+12% +$11.2M 0.01% 1026
2024
Q2 		$86.3M Buy
5,311,156
+1,149,299
+28% +$17.7M 0.01% 1097
2024
Q1 		$58.7M Buy
4,161,857
+1,791,916
+76% +$22.6M 0.01% 1363
2023
Q4 		$24.7M Buy
2,369,941
+107,612
+5% +$1M ﹤0.01% 1945
2023
Q3 		$23.1M Buy
2,262,329
+630,865
+39% +$5.87M ﹤0.01% 1889
2023
Q2 		$12.3M Sell
1,631,464
-634,637
-28% -$5.15M ﹤0.01% 2507
2023
Q1 		$20.1M Buy
2,266,101
+609,864
+37% +$6.03M ﹤0.01% 2120
2022
Q4 		$15.1M Buy
1,656,237
+117,270
+8% +$1.02M ﹤0.01% 2268
2022
Q3 		$12.4M Sell
1,538,967
-120,114
-7% -$1.06M ﹤0.01% 2397
2022
Q2 		$12.5M Sell
1,659,081
-98,381
-6% -$857K ﹤0.01% 2460
2022
Q1 		$16.5M Sell
1,757,462
-773,600
-31% -$6.46M ﹤0.01% 2340
2021
Q4 		$20.3M Sell
2,531,062
-378,693
-13% -$3.42M ﹤0.01% 2200
2021
Q3 		$28.3M Buy
2,909,755
+816,035
+39% +$7.64M ﹤0.01% 1838
2021
Q2 		$20.7M Sell
2,093,720
-817,326
-28% -$8.65M ﹤0.01% 2109
2021
Q1 		$33.6M Buy
2,911,046
+920,376
+46% +$10.6M ﹤0.01% 1594
2020
Q4 		$19.2M Buy
1,990,670
+321,709
+19% +$3.08M ﹤0.01% 1934
2020
Q3 		$15M Buy
1,668,961
+140,532
+9% +$1.49M ﹤0.01% 1940
2020
Q2 		$18.8M Buy
1,528,429
+45,159
+3% +$511K ﹤0.01% 1658
2020
Q1 		$13.3M Buy
1,483,270
+31,098
+2% +$319K ﹤0.01% 1820
2019
Q4 		$14.2M Sell
1,452,172
-218,527
-13% -$1.95M ﹤0.01% 2205
2019
Q3 		$11.5M Buy
1,670,699
+184,607
+12% +$1.41M ﹤0.01% 2355
2019
Q2 		$13.7M Sell
1,486,092
-5,295,929
-78% -$63.9M ﹤0.01% 2216
2019
Q1 		$106M Sell
6,782,021
-169,688
-2% -$2.99M 0.02% 714
2018
Q4 		$107M Buy
6,951,709
+1,106,835
+19% +$22.7M 0.02% 647
2018
Q3 		$126M Buy
5,844,874
+1,798,951
+44% +$41.8M 0.02% 633
2018
Q2 		$98.4M Sell
4,045,923
-193,244
-5% -$3.94M 0.02% 704
2018
Q1 		$72.4M Sell
4,239,167
-5,001,708
-54% -$97.7M 0.01% 856
2017
Q4 		$175M Buy
9,240,875
+6,026,437
+187% +$90.7M 0.03% 494
2017
Q3 		$56.6M Sell
3,214,438
-174,556
-5% -$3.93M 0.01% 1064
2017
Q2 		$113M Sell
3,388,994
-955,383
-22% -$29.6M 0.02% 648
2017
Q1 		$139M Sell
4,344,377
-435,851
-9% -$14.9M 0.03% 555
2016
Q4 		$173M Sell
4,780,228
-2,140,695
-31% -$85.5M 0.04% 444
2016
Q3 		$318M Sell
6,920,923
-318,212
-4% -$16.6M 0.07% 287
2016
Q2 		$364M Sell
7,239,135
-492,749
-6% -$26.2M 0.08% 248
2016
Q1 		$414M Sell
7,731,884
-457,198
-6% -$26.8M 0.1% 215
2015
Q4 		$538M Sell
8,189,082
-312,862
-4% -$19.3M 0.13% 184
2015
Q3 		$480M Buy
8,501,944
+5,510,610
+184% +$357M 0.12% 192
2015
Q2 		$177M Buy
2,991,334
+467,117
+19% +$28.8M 0.06% 356
2015
Q1 		$157M Sell
2,524,217
-138,800
-5% -$8.07M 0.05% 364
2014
Q4 		$153M Buy
2,663,017
+856,254
+47% +$47.7M 0.05% 392
2014
Q3 		$97.1M Sell
1,806,763
-2,801,351
-61% -$148M 0.03% 549
2014
Q2 		$242M Buy
4,608,114
+2,329,726
+102% +$119M 0.08% 272
2014
Q1 		$120M Sell
2,278,388
-23,643
-1% -$1.09M 0.04% 419
2013
Q4 		$92.3M Buy
2,302,031
+506,929
+28% +$20M 0.03% 519
2013
Q3 		$67.8M Sell
1,795,102
-74,099
-4% -$2.89M 0.03% 598
2013
Q2 		$73.3M Buy
+1,869,201
New +$72.8M 0.03% 522

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bank of America's TEVA Position: Q2 2026 in Review

Bank of America increased its Teva Pharmaceuticals (TEVA) stake by 6.8% in Q2 2026, buying an estimated $8.95M and bringing the position to 4,227,607 shares worth $143M. The position accounts for 0.01% of the portfolio, ranked #956.

Bank of America first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $538M in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bank of America held 4,227,607 shares of Teva Pharmaceuticals worth $143M as of Q2 2026.
  • Bank of America bought 268,793 Teva Pharmaceuticals shares in Q2 2026, an estimated $8.95M.
  • Teva Pharmaceuticals made up 0.01% of Bank of America's portfolio in Q2 2026, its #956 holding.
  • Bank of America first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Teva Pharmaceuticals position peaked at $538M in Q4 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.